Epstein-Barr virus antagonizes the antiproliferative activity of transforming growth factor-beta but does not abolish

Manuela Horndasch1, Eva E Raschke, Guido Bommer

  • 1Institute of Clinical Molecular Biology and Tumor Genetics, GSF-Research Center for Environment and Health, Munich, Germany.

Insights

Epstein-Barr virus (EBV) confers resistance to TGF-beta

Area of Science:

  • Molecular Biology
  • Virology
  • Immunology

Background:

  • Transforming growth factor-beta (TGF-beta) typically induces apoptosis and inhibits proliferation in B-lymphoma cells.
  • Epstein-Barr virus (EBV) immortalization confers resistance to TGF-beta's antiproliferative and proapoptotic effects in B cells.

Purpose of the Study:

  • To investigate the mechanism by which EBV overcomes TGF-beta-mediated growth arrest in B cells.
  • To determine if EBV interferes with the core TGF-beta signaling pathway.

Main Methods:

  • Generation of a lymphoblastoid cell line with an inducible EBV-specific transcriptional program (driven by EBNA2).
  • Assessment of TGF-beta responsiveness and target gene induction in EBV-expressing versus EBV-negative cells.

Main Results:

  • EBV-immortalized cells expressing the EBNA2-driven phenotype are resistant to TGF-beta-induced growth arrest.
  • EBV-driven cells remain responsive to TGF-beta, as evidenced by the induction of TGF-beta target genes.
  • EBV overcomes TGF-beta's antiproliferative activity without disrupting the core TGF-beta signaling pathway.

Conclusions:

  • EBV confers resistance to TGF-beta-mediated growth arrest in B cells.
  • This resistance is achieved without interfering with the fundamental TGF-beta signaling cascade.
  • EBV's mechanism of overcoming TGF-beta antiproliferative effects lies downstream of target gene induction.

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...